|
Compositions to Enhance Vaccine Efficacy on Mucosal Surfaces
Targeting moDC to Improve Mucosal Surface ProtectionThis composition targets a subset of dendritic cells that mediate cyclic dinucleotide adjuvant activity, thereby improving mucosal surface protection and response to vaccines. In the 20th century, immunization has allowed us to control several life threatening diseases such as measles, whooping cough,...
Published: 9/3/2021
|
Inventor(s):
Keywords(s): Dendritic Cells, mucosal, prevention, Vaccine, vaccine adjuvant
Category(s): Technology Classifications > Human Health Care > Therapeutics
|
